BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 36635268)

  • 21. Metformin induces FOXO3-dependent fetal hemoglobin production in human primary erythroid cells.
    Zhang Y; Paikari A; Sumazin P; Ginter Summarell CC; Crosby JR; Boerwinkle E; Weiss MJ; Sheehan VA
    Blood; 2018 Jul; 132(3):321-333. PubMed ID: 29884740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tenofovir disoproxil fumarate induces fetal hemoglobin production in K562 cells and β-YAC transgenic mice: A therapeutic approach for γ-globin induction.
    Khan F; Ali H; Musharraf SG
    Exp Cell Res; 2020 Sep; 394(2):112168. PubMed ID: 32653411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cilostazol-mediated reversion of γ-globin silencing is associated with a high level of HbF production: A potential therapeutic candidate for β-globin disorders.
    Ali H; Khan F; Musharraf SG
    Biomed Pharmacother; 2021 Oct; 142():112058. PubMed ID: 34426256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. When basic science reaches into rational therapeutic design: from historical to novel leads for the treatment of β-globinopathies.
    Andrieu-Soler C; Soler E
    Curr Opin Hematol; 2020 May; 27(3):141-148. PubMed ID: 32167946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EHMT1 and EHMT2 inhibition induces fetal hemoglobin expression.
    Renneville A; Van Galen P; Canver MC; McConkey M; Krill-Burger JM; Dorfman DM; Holson EB; Bernstein BE; Orkin SH; Bauer DE; Ebert BL
    Blood; 2015 Oct; 126(16):1930-9. PubMed ID: 26320100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Forced chromatin looping raises fetal hemoglobin in adult sickle cells to higher levels than pharmacologic inducers.
    Breda L; Motta I; Lourenco S; Gemmo C; Deng W; Rupon JW; Abdulmalik OY; Manwani D; Blobel GA; Rivella S
    Blood; 2016 Aug; 128(8):1139-43. PubMed ID: 27405777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural regulatory mutations elevate the fetal globin gene via disruption of BCL11A or ZBTB7A binding.
    Martyn GE; Wienert B; Yang L; Shah M; Norton LJ; Burdach J; Kurita R; Nakamura Y; Pearson RCM; Funnell APW; Quinlan KGR; Crossley M
    Nat Genet; 2018 Apr; 50(4):498-503. PubMed ID: 29610478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correction of sickle cell disease in adult mice by interference with fetal hemoglobin silencing.
    Xu J; Peng C; Sankaran VG; Shao Z; Esrick EB; Chong BG; Ippolito GC; Fujiwara Y; Ebert BL; Tucker PW; Orkin SH
    Science; 2011 Nov; 334(6058):993-6. PubMed ID: 21998251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of Rapamycin as Inducer of Hb F in Primary Erythroid Cultures from Sickle Cell Disease and β-Thalassemia Patients.
    Pecoraro A; Troia A; Calzolari R; Scazzone C; Rigano P; Martorana A; Sacco M; Maggio A; Di Marzo R
    Hemoglobin; 2015; 39(4):225-9. PubMed ID: 26016899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Compounds of the anthracycline family of antibiotics elevate human gamma-globin expression both in erythroid cultures and in a transgenic mouse model.
    Spyrou P; Phylactides M; Lederer CW; Kithreotis L; Kirri A; Christou S; Kkolou E; Kanavakis E; Anagnou NP; Stamatoyannopoulos G; Kleanthous M
    Blood Cells Mol Dis; 2010; 44(2):100-6. PubMed ID: 19914848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A genome-editing strategy to treat β-hemoglobinopathies that recapitulates a mutation associated with a benign genetic condition.
    Traxler EA; Yao Y; Wang YD; Woodard KJ; Kurita R; Nakamura Y; Hughes JR; Hardison RC; Blobel GA; Li C; Weiss MJ
    Nat Med; 2016 Sep; 22(9):987-90. PubMed ID: 27525524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SOX6 Downregulation Induces
    Li J; Lai Y; Luo J; Luo L; Liu R; Liu Z; Zhao W
    Biomed Res Int; 2017; 2017():9496058. PubMed ID: 29333458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hydroxyurea Decouples Persistent F-Cell Elevation and Induction of γ-Globin.
    Walker AL; Crosby D; Miller V; Weidert F; Ofori-Acquah S
    Exp Hematol; 2022; 112-113():15-23.e1. PubMed ID: 35843392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reactivation of Fetal Hemoglobin for Treating β-Thalassemia and Sickle Cell Disease.
    Cui S; Engel JD
    Adv Exp Med Biol; 2017; 1013():177-202. PubMed ID: 29127681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fetal hemoglobin in sickle cell anemia: relation to regulatory sequences cis to the beta-globin gene. Multicenter Study of Hydroxyurea.
    Lu ZH; Steinberg MH
    Blood; 1996 Feb; 87(4):1604-11. PubMed ID: 8608254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A systematic review of known mechanisms of hydroxyurea-induced fetal hemoglobin for treatment of sickle cell disease.
    Pule GD; Mowla S; Novitzky N; Wiysonge CS; Wonkam A
    Expert Rev Hematol; 2015 Oct; 8(5):669-79. PubMed ID: 26327494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dimethyl fumarate increases fetal hemoglobin, provides heme detoxification, and corrects anemia in sickle cell disease.
    Krishnamoorthy S; Pace B; Gupta D; Sturtevant S; Li B; Makala L; Brittain J; Moore N; Vieira BF; Thullen T; Stone I; Li H; Hobbs WE; Light DR
    JCI Insight; 2017 Oct; 2(20):. PubMed ID: 29046485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hydroxyurea differentially modulates activator and repressors of γ-globin gene in erythroblasts of responsive and non-responsive patients with sickle cell disease in correlation with Index of Hydroxyurea Responsiveness.
    Zhu X; Hu T; Ho MH; Wang Y; Yu M; Patel N; Pi W; Choi JH; Xu H; Ganapathy V; Kutlar F; Kutlar A; Tuan D
    Haematologica; 2017 Dec; 102(12):1995-2004. PubMed ID: 28971909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conjugate prodrug AN-233 induces fetal hemoglobin expression in sickle erythroid progenitors and β-YAC transgenic mice.
    Oseghale AR; Zhu X; Li B; Peterson KR; Nudelman A; Rephaeli A; Xu H; Pace BS
    Blood Cells Mol Dis; 2019 Nov; 79():102345. PubMed ID: 31351219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mi2β is required for γ-globin gene silencing: temporal assembly of a GATA-1-FOG-1-Mi2 repressor complex in β-YAC transgenic mice.
    Costa FC; Fedosyuk H; Chazelle AM; Neades RY; Peterson KR
    PLoS Genet; 2012; 8(12):e1003155. PubMed ID: 23284307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.